Abstract
A study on the anti-inflammatory activity of brown alga Sargassum siliquastrum led to the isolation of sargachromanol G (SG). In this study, the anti-inflammatory effect and the action mechanism of SG have been investigated in murine macrophage cell line RAW 264.7. SG dosedependently inhibited the production of inflammatory markers [nitric oxide (NO), inducible nitric oxide synthase (iNOS), prostaglandin E2 (PGE2), and cyclooxygenase-2 (COX-2)] and pro-inflammatory cytokines [tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6] induced by LPS treatment. To further elucidate the mechanism of this inhibitory effect of SG, we studied LPS-induced nuclear factor-κB (NF-κB) activation and mitogen-activated protein kinases (MAPKs) phosphorylation. SG inhibited the phosphorylation IκB-α and NF-κB (p65 and p50) and MAPK (ERK1/2, JNK, and p38) in a dose dependent manner. These results suggest that the anti-inflammatory activity of SG results from its modulation of pro-inflammatory cytokines and mediators via the suppression of NF-κB activation and MAPK phosphorylation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahmad, N., Chen, L. C., Gordon, M. A., Laskin, J. D., and Laskin, D. L., Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. J. Leukoc. Biol., 71, 1005–1011 (2002).
Brown, M. D. and Sacks, D. B., Compartmentalised MAPK pathways. Handb. Exp. Pharmacol., 186, 205–235 (2008).
Ding, C., Cicuttini, F., Li, J., and Jones, G., Targeting IL-6 in the treatment of inflammatory and autoimmune diseases. Expert Opin. Investig. Drugs, 18, 1457–1466 (2009).
Edwards, M. R., Bartlett, N. W., Clarke, D., Birrell, M., Belvisi, M., and Johnston, S. L., Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol. Ther., 121, 1–13 (2009).
Feldmann, M., Brennan, F. M., Chantry, D., Haworth, C., Turner, M., Katsikis, P., Londei, M., Abney, E., Buchan, G., Barrett, K., Corcoran, A., Kissonerghis, M., Zheng, R., Grubeck-Loebenstein, B., Barkley, D., Chu, C. Q., Field, M., and Maini, R. N., Cytokine assays: role in evaluation of the pathogenesis of autoimmunity. Immunol. Rev., 119, 105–123 (1991).
Feldmann, M., Many cytokines are very useful therapeutic targets in disease. J. Clin. Invest., 118, 3533–3536 (2008).
Fernandez, M., Rios, J. C., Jos, A., and Repetto, G., Comparative cytotoxicity of alachlor on RTG-2 trout and SH-SY5Y human cells. Arch. Environ. Contam. Toxicol., 51, 515–520 (2006).
Fogal, B. and Hewett, S. J., Interleukin-1beta: a bridge between inflammation and excitotoxicity? J. Neurochem., 106, 1–23 (2008).
Fujihara, M., Muroi, M., Tanamoto, K., Suzuki, T., Azuma, H., and Ikeda, H., Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther., 100, 171–194 (2003).
Ghosh, S. and Hayden, M. S., New regulators of NF-kappaB in inflammation. Nat. Rev. Immunol., 8, 837–848 (2008).
Guha, M. and Mackman, N., LPS induction of gene expression in human monocytes. Cell Signal., 13, 85–94 (2001).
Heo, S. J., Yoon, W. J., Kim, K. N., Ahn, G. N., Kang, S. M., Kang, D. H., Affan, A., Oh, C., Jung, W. K., and Jeon, Y. J., Evaluation of anti-inflammatory effect of fucoxanthin isolated from brown algae in lipopolysaccharide-stimulated RAW 264.7 macrophages. Food Chem. Toxicol., 48, 2045–2051 (2010).
Ji, R. R., Gereau, R. W., 4th., Malcangio, M., and Strichartz, G. R., MAP kinase and pain. Brain Res. Rev., 60, 135–148 (2009).
Kim, E. Y. and Moudgil, K. D., Regulation of autoimmune inflammation by pro-inflammatory cytokines. Immunol. Lett., 120, 1–5 (2008).
Kim, J. H., Bachmann, R. A., and Chen, J., Interleukin-6 and insulin resistance. Vitam. Horm., 80, 613–633 (2009).
Kofler, S., Nickel, T., and Weis, M., Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin. Sci., 108, 205–213 (2005).
Lapa e Silva, J. R., Possebon da Silva, M. D., Lefort, J., and Vargaftig, B. B., Endotoxin, asthma, and allergic immune responses. Toxicology, 152, 31–35 (2000).
Lee, H. J., Hyun, E. A., Yoon, W. J., Kim, B. H., Rhee, M. H., Kang, H. K., Cho, J. Y, and Yoo, E. S., In vitro antiinflammatory and anti-oxidative effects of Cinnamomum camphora extracts. J. Ethnopharmacol., 103, 208–216 (2006).
Malemud, C. J. and Miller, A, H., Pro-inflammatory cytokineinduced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs. Expert Opin. Ther. Targets, 12, 171–183 (2008).
Mehra, V. C., Ramgolam, V. S., and Bender, J. R., Cytokines and cardiovascular disease. J. Leukoc. Biol., 78, 805–818 (2005).
Murakami, A. and Ohigashi, H., Targeting NOX, iNOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int. J. Cancer, 121, 2357–2363 (2007).
Ren, K. and Torres, R., Role of interleukin-1beta during pain and inflammation. Brain Res. Rev., 60, 57–64 (2009).
Sugita, T., Targeting therapy for inflammatory diseases by anti-TNF-alpha biologics. Yakugaku Zasshi, 129, 19–24 (2009).
Sweet, M. J. and Hume, D. A., Endotoxin signal transduction in macrophages. J. Leukoc. Biol., 60, 8–26 (1996).
Walsh, N. C., Crotti, T. N., Goldring, S. R., and Gravallese, E. M., Rheumatic diseases: the effects of inflammation on bone. Immunol. Rev., 208, 228–251 (2005).
Wong, E. T. and Tergaonkar, V., Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential. Clin. Sci., 116, 451–465 (2009).
Yoon, W. J., Moon, J. Y., Song, G., Lee, Y. K., Han, M. S., Lee, J. S., Ihm, B. S., Lee, W. J., Lee, N. H., and Hyun, C. G., Artemisia fukudo essential oil attenuates LPS-induced inflammation by suppressing NF-kappaB and MAPK activation in RAW 264.7 macrophages. Food Chem. Toxicol., 48, 1222–1229 (2010).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yoon, WJ., Heo, SJ., Han, SC. et al. Anti-inflammatory effect of sargachromanol G isolated from Sargassum siliquastrum in RAW 264.7 cells. Arch. Pharm. Res. 35, 1421–1430 (2012). https://doi.org/10.1007/s12272-012-0812-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-012-0812-5